Home › Funds › 5AM Venture Management, LLC › TRDA
5AM Venture Management, LLC position in TRDA
ENTRADA THERAPEUTICS INC · Health Care
5AM Venture Management, LLC reported holding 3,784,650 shares of TRDA (ENTRADA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$24.0M, representing 8.09% of its reported portfolio and ranking #2 among its reported holdings. 5AM Venture Management, LLC has disclosed TRDA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How 5AM Venture Management, LLC's TRDA position evolved
5AM Venture Management, LLC first disclosed a stake in TRDA in Q3 2023 at 4,408,379 shares (US$69.7M). The position peaked in Q4 2024 at 4,408,379 shares, worth US$76.2M. Across 13 filings, 5AM Venture Management, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 3,784,650 shares valued at US$24.0M — a reduction of -271,729 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.41M | $69.65M | New |
| Q4 2023 | 4.41M | $66.52M | Hold |
| Q1 2024 | 4.41M | $62.47M | Hold |
| Q2 2024 | 4.41M | $62.82M | Hold |
| Q3 2024 | 4.41M | $70.45M | Hold |
| Q4 2024 | 4.41M | $76.22M | Hold |
| Q1 2025 | 4.41M | $39.85M | Hold |
| Q2 2025 | 4.31M | $28.95M | Reduce |
| Q3 2025 | 4.26M | $24.69M | Reduce |
| Q4 2025 | 4.06M | $41.70M | Reduce |
| Q1 2026 | 4.06M | $51.19M | Hold |
| Q2 2026 | 4.06M | $29.85M | Hold |
| Q3 2026 | 3.78M | $24.03M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TRDA and 13F data
TRDA (ENTRADA THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in TRDA — the largest reported positions include BAKER BROS. ADVISORS LP (US$32.2M), Merck & Co., Inc. (US$11.0M), Trails Edge Capital Partners, LP (US$9.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRDA
- BAKER BROS. ADVISORS LP 5.07M sh · $32.21M · Q3 2026
- Merck & Co., Inc. 1.74M sh · $11.05M · Q3 2026
- Trails Edge Capital Partners, LP 1.43M sh · $9.07M · Q3 2026
- TCG Crossover Management, LLC 1.06M sh · $6.73M · Q3 2026
- StepStone Group LP 761.28K sh · $5.60M · Q2 2026
- Lynx1 Capital Management LP 278.61K sh · $1.77M · Q3 2026
More on 5AM Venture Management, LLC
FAQ
How long has 5AM Venture Management, LLC held TRDA?
5AM Venture Management, LLC has disclosed TRDA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is 5AM Venture Management, LLC's current position in TRDA?
As of Q3 2026, 5AM Venture Management, LLC holds 3.78M shares of TRDA (ENTRADA THERAPEUTICS INC), valued at $24.03M, representing 8.09% of its reported portfolio and ranking #2.
Has 5AM Venture Management, LLC been buying or selling TRDA?
In the latest 13F filing (Q3 2026), 5AM Venture Management, LLC reduced its position in TRDA. The position peaked in Q4 2024 at 4.41M shares.
Which other funds hold TRDA?
Other major institutional holders of TRDA include BAKER BROS. ADVISORS LP, Merck & Co., Inc., Trails Edge Capital Partners, LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.